Background Experimental evidence suggests that anesthetics accelerate symptomatic neurodegenerative disorders like Alzheimer disease (AD). Since AD pathology precedes symptoms, we asked whether anesthetic exposure in the presymptomatic interval accelerates neuropathology and appearance of symptoms. Methods Triple transgenic Alzheimer mice exposed to the general aesthetics, halothane or isoflurane, at 2, 4 and 6 months of age, underwent water maze cognitive testing two months afterwards and their brains subsequently analyzed with ELISA, immunoblots, and immunohistochemistry for amyloid and tau pathology and biomarkers. Results Learning and memory improved after halothane exposure in the 2 month old group relative to controls, but no changes were noted in any isoflurane group. When gender was examined in all age groups, females exposed to halothane performed better than females exposed to isoflurane or controls. Thus, improvement in the 2 month exposure group is most likely due to a gender effect. Phospho-tau in the hippocampus was significantly increased two months after anesthesia, especially in the 6 month exposure group but changes in amyloid, caspase, microglia or synaptophysin were not detected. Conclusions These results indicate that exposure to two different inhalational anesthetics during the presymptomatic period of AD does not accelerate cognitive decline, two months later, and may cause a stress response, marked by hippocampal phosphorylated tau, resulting in preconditioning against the ongoing neuropathology, primarily in female mice.
BACKGROUND The number of elderly patients with frank or incipient Alzheimer’s disease (AD) requiring surgery is growing as the population ages. General anesthesia may exacerbate symptoms of and the pathology underlying AD, so minimizing anesthetic exposure may be important. This requires knowledge of whether the continuing AD pathogenesis alters anesthetic potency. METHODS We determined the induction potency and emergence time for isoflurane, halothane, and sevoflurane using the minimum alveolar anesthetic concentration for loss of righting reflex as an end point in 12- to 14-mo-old triple transgenic Alzheimer (3xTgAD) mice and wild type C57BL6 controls. 3xTgAD mice model AD by harboring three distinct mutations: the APPSwe, Tau, and PS1 human transgenes, each of which has been associated with familial forms of human AD. RESULTS The 3xTgAD mice exhibited mild resistance (from 8% to 30%) to volatile anesthetics but displayed indistinguishable emergence patterns from all three inhaled anesthetics. CONCLUSIONS These results show that the genetic vulnerabilities and neuropathology associated with AD produce a small but significant decrease in sensitivity to the hypnotic actions of three inhaled anesthetics. Emergence times were not altered.
Hydrogen sulfide (H 2 S) depresses mitochondrial function and thereby metabolic rates in mice, purportedly resulting in a state of "suspended animation." Volatile anesthetics also depress mitochondrial function, an effect that may contribute to their anesthetic properties. In this study, we ask whether H 2 S has general anesthetic properties, and by extension, whether mitochondrial effects underlie the state of anesthesia. We compared loss of righting reflex, electroencephalography, and electromyography in mice exposed to metabolically equipotent concentrations of halothane, isoflurane, sevoflurane, and H 2 S. We also studied combinations of H 2 S and anesthetics to assess additivity. Finally, the long-term effects of H 2 S were assessed by using the Morris water maze behavioral testing 2 to 3 weeks after exposures. Exposure to H 2 S decreases O 2 consumption, CO 2 production, and body temperature similarly to that of the general anesthetics, but fails to produce a loss of righting reflex or muscle atonia at metabolically equivalent concentrations. When combined, H 2 S antagonizes the metabolic effects of isoflurane, but potentiates the isoflurane-induced loss of righting reflex. We found no effect of prior H 2 S exposure on memory or learning. H 2 S (250 ppm), not itself lethal, produced delayed lethality when combined with subanesthetic concentrations of isoflurane. H 2 S cannot be considered a general anesthetic, despite similar metabolic suppression. Metabolic suppression, presumably via mitochondrial actions, is not sufficient to account for the hypnotic or immobilizing components of the anesthetic state. Combinations of H 2 S and isoflurane can be lethal, suggesting extreme care in the combination of these gases in clinical situations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.